Arena Pharma (ARNA) Earns Prime Status from ISS ESG, a Leading Rating Agency for Sustainable Investments

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced it has been designated Prime in the ISS ESG Corporate Rating, effective as of May 4, 2021. Companies are classified as Prime when their ESG performance exceeds the threshold criteria for companies in its sector, meaning they fulfill ambitious absolute performance requirements.

The ISS ESG Corporate Rating sets the industry standard for sustainable investing and is used by international institutional investors and financial service companies to inform their decisions. According to this rating, Arena tradeable bonds and shares will now qualify for responsible investment.

“This rating reinforces our far-reaching efforts to build a vibrant, sustainable enterprise with the ultimate goal of delivering our important medicines to patients who need them,” said Laurie Stelzer, Chief Financial Officer of Arena Pharmaceuticals. “Our management team, our employees, and our Board of Directors all embrace a long-term commitment to ESG principles for the betterment of our company and the communities we are working in. We are proud to be recognized as not only a sustainable company, but also a sustainable investment.”

The Prime status follows the release of Arena’s second annual ESG report in April 2021, outlining the Company’s long-term commitment to the betterment of society, focusing on patients, employees, the community, the environment, and shareholders.

For more information on the ISS ESG Corporate Rating, please visit: issgovernance.com/esg/ratings/.

View the full 2021 Arena ESG Report on the Arena Investors page: https://invest.arenapharm.com/.

You May Also Be Interested In

• Mondi Says It Does Not Intend To Make An Offer For DS Smith
• Lifeward (LFWD) Announces the Appointment of Mike Swinford to its Board of Directors
• ContextLogic (WISH) Receives Stockholder Approval of Transaction with Qoo10